Ferrer Internacional S.A.
Dr. Jorge Gonzalez Borroto (PharmD, Ph.D) is Senior Nonclinical Toxicologist and Pharmacovigilance Officer in the pharmaceutical company Ferrer Internacional S.A., Barcelona, Spain. He accomplished his Ph.D in Genetic, specialization in Genetic Toxicology from Autonomous University of Barcelona (UAB, Barcelona, Spain). He has been involved in development of new testing strategies for predictive toxicology through validation of novel tests and cell-based assays in drug discovery, development of new biomarkers for assessment of toxicological effects in animal models and integration of in vitro and in vivo safety results during drugs development to obtain safer drugs for human use.
Toxicology Evaluation in Drug Development; New Methodologies for Predictive Toxicology; New Animals Models for Safety Evaluation; Biomarkers for Drug Safety Assessment.